In the brain, many types of interneurons make functionally diverse inhibitory synapses onto principal neurons. Although numerous molecules have been identified to function in inhibitory synapse development, it remains unknown whether there is a unifying mechanism for development of diverse inhibitory synapses. Here we report a general molecular mechanism underlying hippocampal inhibitory synapse development. In developing neurons, the establishment of GABAergic transmission depends on Neuroligin 2 (NL2), a synaptic cell adhesion molecule (CAM). During maturation, inhibitory synapse development requires both NL2 and Slitrk3 (ST3), another CAM. Importantly, NL2 and ST3 interact with nanomolar affinity through their extracellular domains to synergistically promote synapse development. Selective perturbation of the NL2-ST3 interaction impairs inhibitory synapse development with consequent disruptions in hippocampal network activity and increased seizure susceptibility. Our findings reveal how unique postsynaptic CAMs work in concert to control synaptogenesis and establish a general framework for GABAergic synapse development.
Pubmed ID: 29107521 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
A commercial graphing software company that offers scientific software for statistical analyses, curve fitting and data analysis. It offers four programs: Prism, InStat, StatMate and QuickCalcs.
View all literature mentionsThis unknown targets ANTI-FLAG(R) M2 Affinity Gel
View all literature mentionsThis unknown targets Protein A/G PLUS-Agarose
View all literature mentionsThis polyclonal targets Anti-Guinea Pig IgG (H+L)
View all literature mentionsThis polyclonal targets Mouse IgG (H+L)
View all literature mentionsThis polyclonal targets Rabbit IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgY (H+L)
View all literature mentionsThis unknown targets Human IgG, Fc? Fragment Specific
View all literature mentionsThis polyclonal targets Tau
View all literature mentionsThis polyclonal targets Microtubule-Associated Protein (MAP2)
View all literature mentionsThis polyclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis monoclonal targets HA-Tag
View all literature mentionsThis monoclonal targets Human, Mouse gephyrin
View all literature mentionsThis monoclonal targets Gephyrin
View all literature mentionsThis monoclonal targets Neuroligin 2
View all literature mentionsThis monoclonal targets Neuroligin 1
View all literature mentionsThis monoclonal targets Post Synaptic Density Protein 95 (PSD-95)
View all literature mentionsThis monoclonal targets Tubulin, alpha
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis unknown targets Murine IgG Control
View all literature mentionsThis monoclonal targets Myc-Tag
View all literature mentionsThis polyclonal targets FLAG
View all literature mentionsThis polyclonal targets Neuroligin 3
View all literature mentionsThis polyclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis polyclonal targets HA-probe
View all literature mentionsThis polyclonal targets Slitrk3
View all literature mentionsThis polyclonal targets SLITRK3
View all literature mentionsThis polyclonal targets KLH-conjugated linear peptide corresponding to human Slitrk3.
View all literature mentionsMus musculus with name B6;129-Nlgn2tm1Bros/J from IMSR.
View all literature mentions